Viewing Study NCT05176704


Ignite Creation Date: 2025-12-24 @ 9:18 PM
Ignite Modification Date: 2025-12-24 @ 9:18 PM
Study NCT ID: NCT05176704
Status: RECRUITING
Last Update Posted: 2024-02-13
First Post: 2021-12-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease
Sponsor: Innodem Neurosciences
Organization:

Study Overview

Official Title: Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease
Status: RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to develop and validate a sensitive and non-invasive eye-tracking software application.

This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by Alzheimer's Disease and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of Alzheimer's Disease and associated cognitive changes.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: